Majority of Americans Favor Accessible Early Screening for Alzheimer's Disease

A recent survey highlighted that most Americans are eager to undergo simple and early testing for Alzheimer's disease, aiming to identify the condition before symptoms significantly impair daily life. According to the 2025 Alzheimer's Association report, approximately 79% of those surveyed want to learn if they are at risk for Alzheimer's even before any symptoms appear, emphasizing a strong desire for proactive health management.

The survey also revealed that 92% of Americans are willing to consider medications that could slow the disease's progression, even if such treatments carry moderate to high risks. Notably, about 58% are open to accepting significant risks from treatments if they offer potential benefits in delaying the disease.

Elizabeth Edgerly, the Alzheimer's Association's senior director for community programs and services, explained that the findings show a clear public demand for easier-to-access testing options. Current diagnostic methods are often complex and not widely available, which creates barriers to early detection. The community's interest in early diagnosis and treatment options underscores the importance of developing simple, accessible testing methods.

Today, over 7 million Americans are living with Alzheimer's, with the number expected to rise to 7.2 million among those aged 65 and older. Despite the absence of a simple test currently, 91% of survey respondents expressed interest in utilizing a straightforward blood test or similar minimally invasive screening to assess their risk.

Furthermore, a significant proportion—83%—are willing to participate in clinical trials if diagnosed, driven by a desire to access emerging treatments. This highlights a proactive attitude toward managing the disease and a hope for advancements in therapies.

While optimism about new treatments is high, with 81% believing effective therapies to slow or prevent Alzheimer's will be available within the next decade, concerns about healthcare coverage remain. About 44% worry that insurance might not cover the costs associated with diagnosis and treatment.

This survey, conducted among 1,702 adults aged 45 and older from November 7 to 18, 2024, underscores a collective desire for earlier detection and intervention, alongside the need for improved access and affordable care to combat the rising prevalence of Alzheimer's disease.